tiprankstipranks

Thomas Charles Heineman Insider Profile

11 Followers
Thomas Charles Heineman, CMO at Oncolytics Biotech, holds 282.82K shares in Oncolytics Biotech (Ticker: ONCY). Most recently, Thomas Charles Heineman Bought 12,132 shares of Oncolytics Biotech on Feb 13, 2026 for an estimated value of $9.95K.
tipranks
Thomas Charles Heineman

Thomas Charles Heineman
Oncolytics Biotech (ONCY)
CMO

Not Ranked
Thomas Charles Heineman has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$236K
100.00%
A breakdown of Thomas Charles Heineman's holdings

Insider Roles

Oncolytics Biotech
(ONCY)
CMO
Roles that Thomas Charles Heineman holds in companies

Most Profitable Insider Trade

Currently, no data available
The most profitable trade made by Thomas Charles Heineman

Thomas Charles Heineman's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Oncolytics Biotech
Feb 13, 2026
CMO
Informative Buy
9.95K
$236.44K
Date
Transaction
Amount
No. of Shares
Price per Share
Profit
Link to Report
Feb 13, 2026
Informative Buy
$9.95K
12,132
$0.82
List of latest transactions for each holding click on a transaction to see Thomas Charles Heineman's performance on stock

Thomas Charles Heineman insider profile FAQ

What is the percentage of profitable transactions made by Thomas Charles Heineman?
The percentage of profitable transactions made by Thomas Charles Heineman is ―.
    What is the average return per transaction made by Thomas Charles Heineman?
    The average return per transaction made by Thomas Charles Heineman is ―.
      What stocks does Thomas Charles Heineman hold?
      Thomas Charles Heineman holds: ONCY stocks.
        What was Thomas Charles Heineman’s latest transaction?
        Thomas Charles Heineman latest transaction was an Informative Buy of $9.95K.
          What was Thomas Charles Heineman's most profitable transaction?
          Thomas Charles Heineman’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
            What is Thomas Charles Heineman's role in Oncolytics Biotech?
            Thomas Charles Heineman's role in Oncolytics Biotech is CMO.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.